Trials / Conditions / Chronic Weight Management

Chronic Weight Management

7 registered clinical trials studyying Chronic Weight Management.

Status	Trial	Sponsor	Phase
Completed	A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Wei NCT07002905	Ascletis Pharma (China) Co., Limited	Phase 2
Completed	A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With S NCT06972992	Ascletis Pharma (China) Co., Limited	Phase 1
Active Not Recruiting	A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least NCT06703021	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	Phase 2
Completed	Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects NCT06671821	Shandong Suncadia Medicine Co., Ltd.	Phase 2
Active Not Recruiting	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participant NCT06679959	Ascletis Pharma (China) Co., Limited	Phase 1 / Phase 2
Completed	A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese NCT06427590	Ascletis Pharma (China) Co., Limited	Phase 1
Completed	A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-t NCT01987427	Eisai Inc.	Phase 4